Hydrochlorothiazide
Product Images NDC 10544-197

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 10544-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12-5mg 30ct (Label Hydrochlorothiazide Caps 12 5mg Bpi(10544 197 30) Watson(0591 0347 05) Rev0)

12-5mg 30ct (Label Hydrochlorothiazide Caps 12 5mg Bpi(10544 197 30) Watson(0591 0347 05) Rev0)
Hydrochlorothiazide Capsules, 12.5 mg, label from Blenheim Pharmacal, Inc. The label shows product details including 30 capsules per container, Rx only, storage instructions, manufacturer information, and multiple barcodes. It also includes space for lot number and expiration date.*
FDA Label Image

Structure (Hydrochlorothiazide Capsule 1)

Structure (Hydrochlorothiazide Capsule 1)
Chemical structure of Hydrochlorothiazide showing its molecular framework with a benzothiadiazine ring, chlorine substitution, and sulfonamide groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.